Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do
- PMID: 28394489
- PMCID: PMC6309190
- DOI: 10.1111/ajt.14140
Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do
Keywords: cancer/malignancy/neoplasia; comorbidities; disease pathogenesis; editorial/personal viewpoint; hematology/oncology; immune deficiency; immunosuppressant; immunosuppression/immune modulation; translational research/science.
Conflict of interest statement
Disclosure
The author of this manuscript has no conflicts of interest to disclose as described by the
Comment on
-
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.Am J Transplant. 2017 Aug;17(8):1974-1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10. Am J Transplant. 2017. PMID: 28394486 Review.
References
-
- Hoover R, Fraumeni JF Jr. Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55–57. - PubMed
-
- Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59–67. - PubMed
-
- Krynitz B, Edgren G, Lindelof B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008–A Swedish population-based study. Int J Cancer 2013; 132: 1429–1438. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
